BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 45 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,040 | -1.3% | 32,000 | 0.0% | 0.00% | – |
| Q2 2023 | $31,433 | -4.3% | 32,000 | 0.0% | 0.00% | – |
| Q1 2023 | $32,831 | -3.3% | 32,000 | 0.0% | 0.00% | – |
| Q4 2022 | $33,962 | +6.1% | 32,000 | 0.0% | 0.00% | – |
| Q3 2022 | $32,000 | 0.0% | 32,000 | 0.0% | 0.00% | – |
| Q2 2022 | $32,000 | 0.0% | 32,000 | 0.0% | 0.00% | – |
| Q1 2022 | $32,000 | -3.0% | 32,000 | 0.0% | 0.00% | – |
| Q4 2021 | $33,000 | 0.0% | 32,000 | 0.0% | 0.00% | – |
| Q3 2021 | $33,000 | 0.0% | 32,000 | 0.0% | 0.00% | – |
| Q2 2021 | $33,000 | +3.1% | 32,000 | 0.0% | 0.00% | – |
| Q1 2021 | $32,000 | -5.9% | 32,000 | 0.0% | 0.00% | – |
| Q4 2020 | $34,000 | – | 32,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 16,298,000 | $15,340,000 | 1.64% |
| ZAZOVE ASSOCIATES LLC | 25,540,000 | $24,103,000 | 1.55% |
| PIER 88 INVESTMENT PARTNERS LLC | 3,030,000 | $2,844,000 | 1.36% |
| Jabre Capital Partners S.A. | 5,500,000 | $5,184,000 | 1.12% |
| Sonora Investment Management, LLC | 7,100,000 | $6,681,214,000 | 1.06% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 43,256,000 | $40,793,000 | 0.80% |
| Opera Trading Capital | 10,000,000 | $9,370,000 | 0.72% |
| AQR Arbitrage LLC | 52,575,000 | $49,486,000 | 0.57% |
| Neuberger Berman Group LLC | 5,000,000 | $469,375,000 | 0.54% |
| CQS Cayman LP | 12,000,000 | $11,322,000 | 0.52% |